Annual CFO
-$6.25 M
-$2.07 M-49.46%
March 1, 2024
Summary
- As of February 24, 2025, VRAX annual cash flow from operations is -$6.25 million, with the most recent change of -$2.07 million (-49.46%) on March 1, 2024.
- During the last 3 years, VRAX annual CFO has fallen by -$5.66 million (-958.45%).
- VRAX annual CFO is now -958.45% below its all-time high of -$590.20 thousand, reached on March 31, 2021.
Performance
VRAX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VRAX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.5% | - | - |
| 3 y3 years | -958.5% | - | - |
| 5 y5 years | -739.0% | - | - |
VRAX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -958.5% | at low | ||||
| 5 y | 5-year | -958.5% | at low | ||||
| alltime | all time | -958.5% | at low |
Virax Biolabs Group Limited Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$6.25 M(+49.5%) | - | - |
| Mar 2023 | -$4.18 M(+416.6%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | -$809.10 K(+37.1%) | - | - |
| Mar 2021 | -$590.20 K(-20.7%) | - | - |
| Mar 2020 | -$744.60 K | - | - |
FAQ
- What is Virax Biolabs Group Limited annual cash flow from operations?
- What is the all time high annual CFO for Virax Biolabs Group Limited?
- What is Virax Biolabs Group Limited annual CFO year-on-year change?
What is Virax Biolabs Group Limited annual cash flow from operations?
The current annual CFO of VRAX is -$6.25 M
What is the all time high annual CFO for Virax Biolabs Group Limited?
Virax Biolabs Group Limited all-time high annual cash flow from operations is -$590.20 K
What is Virax Biolabs Group Limited annual CFO year-on-year change?
Over the past year, VRAX annual cash flow from operations has changed by -$2.07 M (-49.46%)